UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000007141
Receipt number	R000008409
Scientific Title	Multicenter Phase II Clinical Study of the Safety and Efficacy of Discontinuing Nilotinib Treatment in Patients with Chronic Phase Chronic Myelogenous Leukemia Who Have Achieved Complete Molecular Response with Imatinib or Nilotinib
Date of disclosure of the study information	2012/02/01
Last modified on	2013/08/19 10:31:38

---